EX-10.29
from S-4
102 pages
Candid Therapeutics, Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: May 1, 2024 Approved by the Stockholders: May 1, 2024 Amended by the Board of Directors: June 1, 2024 Approved by the Stockholders: June 1, 2024 Amended by the Board of Directors: August 19, 2024 Approved by the Stockholders: August 19, 2024 Termination Date: May 1, 2034
12/34/56